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Abstract
Estimation of immunological and microbiological diversity is vital to our understanding of infection and the immune
response. For instance, what is the diversity of the T cell repertoire? These questions are partially addressed by high-
throughput sequencing techniques that enable identification of immunological and microbiological ‘‘species’’ in a sample.
Estimators of the number of unseen species are needed to estimate population diversity from sample diversity. Here we test
five widely used non-parametric estimators, and develop and validate a novel method, DivE, to estimate species richness
and distribution. We used three independent datasets: (i) viral populations from subjects infected with human T-
lymphotropic virus type 1; (ii) T cell antigen receptor clonotype repertoires; and (iii) microbial data from infant faecal
samples. When applied to datasets with rarefaction curves that did not plateau, existing estimators systematically increased
with sample size. In contrast, DivE consistently and accurately estimated diversity for all datasets. We identify conditions that
limit the application of DivE. We also show that DivE can be used to accurately estimate the underlying population
frequency distribution. We have developed a novel method that is significantly more accurate than commonly used
biodiversity estimators in microbiological and immunological populations.
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Introduction
How can we estimate diversity from a population sample? In
viral infections, the number of viral variants and their population
structure inform our understanding of disease pathogenesis, and
can suggest treatment strategies [1,2]. In immunology, the
repertoire and population structure of B cell and T cell receptor
clonotypes vary with age [3–7], and are intimately linked to
antimicrobial protective efficacy. In the human microbiome,
decreased diversity of the gastrointestinal microbiota is associated
with atopy [8], Crohn’s disease and ulcerative colitis [9,10].
A complete census is usually impossible and so estimators of the
number of unseen ‘‘species’’ are required. Here we use the word
‘‘individual’’ to refer to a single T cell sequence read, microbial
sequence read, or virus- infected cell. We use ‘‘species’’ to denote a
class of individuals, such a T cell clonotype, bacterial operational
taxonomic unit (OTU) or viral clone. The term ‘‘species richness’’
denotes the number of species in the population under consider-
ation.
Immunological and microbiological data differ in important
respects from ecological data. First, in many immunological
and microbiological populations, it may be reasonable to assume
that ‘‘species’’ are taxonomically similar, that the spatial distribu-
tion of individuals is homogeneous, and that individuals are
sampled randomly, independently and with equal probabilities. If
made, these simplifying assumptions allow the extrapolation of
individual-based rarefaction curves, which depict the expected
number of species against the number of individuals sampled
[11–14]. However, the above assumptions are frequently violated
in ecological populations [14–18], where unobserved individuals
may differ from observed individuals in their colour, physical size,
geographical distribution, movement, variety of habitats and
relationship to other species [15], and thus remain unobserved
despite substantial subsequent sampling. Second, many common
assumptions about population structure are inappropriate for
immunological and microbiological populations, for example that
all species have equal frequencies [19–21], or that the functional
form of the population distribution is known [22–26]. We
therefore consider non-parametric estimators.
Non-parametric estimators, such as Chao1 [27], and the
abundance-based coverage estimator (ACE) [28], have been
proposed. ACE has been suggested to be the best current
approach [14,22,29] and is widely applied in microbiology and
immunology; for example to estimate the diversity of the human
gastrointestinal flora [30], human gut metagenome [31], mouse
TCR repertoire [32,33], fungi [34], and the number of HTLV-1
infected cell clones [35]. Although they were originally intended as
methods to estimate lower bounds, the Chao1 estimator, and the
modified, bias-corrected form Chao1bc [36], have been used to
make a point estimate of the number of TCR clonotypes [37,38],
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the number of OTUs in hepatitis C virus infection [1], parasite
diversity in malaria infection [39] metagenome size [40], the
number of integration sites of therapeutic gene therapy vectors
[41], soil diversity [42], and again the number of HTLV-1 infected
cell clones [35,43]. In addition to the ACE and the Chao
estimator, we also consider two additional non-parametric
estimators: the Bootstrap [44] and Good-Turing estimators [45].
Most diversity estimators aim to estimate the species richness in
one of two populations of interest: either in the population from
which the sample was drawn (e.g. number of microbial species in
the gut, given a sample from the gut) or the value where the
rarefaction curve saturates (e.g. number of species at the point
when further sampling does not yield any new species). These
definitions of the population of interest lack flexibility and may be
inappropriate or poorly defined for the question in hand. Indeed,
if some species are represented by a single individual, the
rarefaction curve will not saturate. For many microbiological
and immunological questions, an estimator that allows the user to
specify the size of the population of interest is desirable. For
instance, we may wish to know the T cell repertoire diversity of
both the blood and the whole body.
The aim of this study was to identify a suitable method for
estimating species richness in immunological and microbiological
populations. We tested widely-used estimators on samples of
microbiological and immunological populations. We found these
estimators performed poorly. We therefore developed and
validated a new method to estimate species richness and species
frequencies.
We used data from three independent sources: (i) viral
populations from human T-lymphotropic virus type-1 (HTLV-
1)–infected subjects; (ii) T cell antigen receptor (TCR) clonotype
repertoires; and, (iii) infant faecal microbial samples.
HTLV-1 is a retrovirus that mainly infects CD4+ T lympho-
cytes. HTLV-1 spreads within hosts via two routes: de novo
infection of uninfected cells, and proliferation of infected cells [46].
When an infected cell proliferates, the integrated provirus is
replicated with the host genome and a clone of infected cells is
generated, each cell carrying a provirus in the same genomic site.
Consequently, in each host, HTLV-1 persists in many distinct
infected cell clones. We used high-throughput data on the
abundance of HTLV-1 infected cell clones in 14 HTLV-1
seropositive subjects [43].
The human gastrointestinal tract contains a densely populated
ecosystem of microbes that performs a variety of functions [47].
We obtained high-throughput 16S rRNA sequence data from
infant faecal samples. In this study we used observed frequencies of
different bacterial operational taxonomic units (OTUs) [48].
T cells are vital to adaptive immunity. The T cell population
comprises a diverse repertoire of TCR clonotypes, each defined by
the DNA sequence of the expressed TCR. In humans, there are a
potential 1015–1020 different TCR clonotypes [49], but the actual
number of clonotypes in one person is estimated to be between 106
and 108 [50]. In this study we used RACE-based data on TCR
clonotype abundance. We studied circulating central and effector
memory, naı¨ve and total CD4+ and CD8+ T cells.
Materials and Methods
Ethics Statement
Blood samples were donated by HTLV-1+ subjects attending
the HTLV-1 clinic at the National Centre for Human Retrovi-
rology (Imperial College Healthcare NHS trust) at St. Mary’s
Hospital, London UK, with fully informed written consent.
This study was approved by the UK National Research Ethics
Service (NRES reference 09/H0606/106). Parents gave full
written informed consent for infant faecal sample collection, and
all protocols and procedures were approved by the National
Research Ethics Service Committee, U.K. (Southampton and
South West Hampshire) (ref: 05/Q1702/119). For the TCR data,
leukaphereses were performed on healthy donors who provided
written informed consent at the National Institutes of Health,
USA. The protocol and use of these samples for immunological
investigation were approved by the National Institute of Allergy
and Infectious Diseases Institutional Review Board.
HTLV-1 Data Collection
Previously reported [43] and new high-throughput data on
HTLV-1 clonality were analysed. Each HTLV-1 dataset quanti-
fies the abundance of HTLV-1-infected T cell clones. There were
105 datasets, comprising nine samples from each of 11 subjects
(three independent samples at each of three time points), and 15
samples from four subjects. All had either HTLV-1-associated
myelopathy/tropical spastic paraparesis or were asymptomatic
carriers of HTLV-1.
Microbial Data Collection
The microbial data were derived from faecal samples obtained
from 10 infants. DNA was amplified with two sets of PCR primers,
generating 20 datasets [48]. Amplicons of the V3-V5 regions of
the 16S rRNA gene were generated by PCR using two sets of
universal primers. Sequencing data were generated using the
Roche 454 GS Junior platform. Analysis was performed using the
QIIME pipeline as described previously [48].
TCR Data Collection
A total of 16 datasets were collected from two subjects,
comprising TCR sequences from four phenotypically defined
subsets of CD4+ and CD8+ T-cells: naı¨ve, central memory (CM),
effector memory (EM) and total. After flow cytometric sorting and
cell lysis, mRNA was extracted and subjected to a non-nested,
template-switch anchored RT-PCR using a 39 TCRB constant
region primer as described previously [51]. This approach allows
Author Summary
The ‘‘unseen species problem’’ is ubiquitous in biology and
is frequently encountered outside its original setting in
population ecology. For example, the human retrovirus
HTLV-1 persists within hosts in multiple, genetically
identical clones of infected cells. However, the number
of clones in one host is unknown; this knowledge is
required for an understanding of how the virus survives
despite a strong host immune response. The problem
arises again in estimating the diversity of the T-cell
repertoire, which influences adaptive immunity. For
example, the T-cell diversity may influence the outcome
of viral challenge. While there have been numerous
attempts to address the unseen species problem, there is
currently no consensus on how to do so in immunology
and microbiology. The aim of this study was to identify a
suitable method to estimate the number of species in
immunological and microbiological populations. We found
that five existing estimators we tested performed poorly
across three data sources (HTLV-1 clonality, T cell receptor,
and microbial data). We therefore developed a new
estimator, DivE, which significantly outperformed the other
estimators. Accurate diversity quantification allows better
evaluation of the impact on immunity from factors such as
ageing and infection.
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linear and unbiased amplification of all TCRs irrespective of
TRBV or TRBJ gene usage. Paired-end sequencing reactions (each
150 bp) were performed using an Illumina HiSeq 2000 sequencer.
Raw FASTQ files were annotated using reference TCRB
sequences from the ImMunoGeneTics (IMGT) website (http://
www.imgt.org) and a custom-written Java application. Following
annotation, the data were filtered to eliminate potential sequenc-
ing and PCR errors.
Prochlorococcus Data Collection
Prochlorococci are vital to energy and nutrient cycling in the
oceanic ecosystem, and the genus contains a highly diverse and
abundant population of clades. We analysed publicly available
metagenomic data describing clades Prochlorococcus. The data were
obtained by the Global Ocean Sampling Expedition and contains
the frequency of distinct sequence reads of genes of Prochlorococcus
clades.[52] Sampling sites, sample collection, library construction,
fragment recruitment, and determination of Prochlorococcus abun-
dances are detailed in [52,53].
DivE Species Richness Estimator
We developed a heuristic approach to estimate species richness,
which we named DivE (Diversity Estimator) (Figure 1). To
calculate the DivE estimator, many mathematical models are
fitted to multiple nested subsamples of individual-based rarefaction
curves. Each model is fitted to all nested subsamples, and is scored
on a set of four criteria. The five best-performing models are
extrapolated and their respective estimates are aggregated to
produce the DivE species richness estimate. DivE requires an
estimate of population size. If the species richness of a wider
population is desired, the same models are used but extrapolated
to a different population size; this is only justified if the two
populations are similar in their spatial distribution of individuals.
The criteria against which each model fit is scored are:
1) Discrepancy – the mean percentage error between data
points and model prediction.
2) Accuracy – the percentage error between the full sample
species richness, and the estimate of full sample species
richness from a given subsample.
3) Similarity – the area between the curve fitted to a subsample
and the curve fitted to the full sample, normalized to the area
under the curve from the full data, on the interval [0, Nobs],
where Nobs is the size of the full data.
4) Plausibility – the predicted number of species must either
increase monotonically or plateau and the predicted rate of
species accumulation must either decrease or plateau (i.e. for
S(x) and x$1, where x is the number of individuals, S9(x) $0,
and S"(x) #0).
The rationale behind each criterion is as follows:
1) Discrepancy - the model must describe the data to which it
was fitted.
2) Accuracy - from a subsample, the model should predict the
full sample species richness.
3) Similarity - an ideal model will produce identical fits from
all subsamples. The smaller the area between the model fits,
the better the model.
4) Plausibility - this criterion requires that, as the observed
number of individuals increases, the observed number of
species does not decrease and the rate of species-accumulation
does not increase; the former is impossible and the latter is
implausible (Figure 1).
Criteria 2), 3) and 4) are independent of the fitting process. That
is, they are not constraints by which models are fitted; instead they
are tests of model performance.
Each model fit is scored on all four criteria. For criteria 1–3, we
scored a fit in multiples of empirically chosen precision levels. The
precision level for criterion 1 was 0.01%: a score of 1 denotes a
model fit where the mean percentage error of the residuals, e, was
less than 0.01%; a score of 2 denotes 0.01%,e#0.02% and so on.
Criteria 2 and 3 were similarly scored in multiples of 0.5%.
Criterion 4 was implemented by giving a score of 500 to model
fits that violated either of its conditions; this value was chosen to
exceed the score of any model fit that satisfied this criterion.
The final score for each model is an aggregate of the scores of
all model fits across subsamples and criteria, and is calculated as
follows. First, the score for each criterion is defined as the mean of
the scores of all subsample fits for that criterion. The final score for
each model is the mean of all criteria scores. The DivE species
richness estimate is the geometric mean of the estimates provided
by the five best-performing (i.e. lowest-scoring) models.
Figure 1. Outline of DivE species richness estimator. DivE fits many models to rarefaction curves (black) and subsamples thereof (orange). Data
is denoted by circles; fits by solid lines. Models are scored according to the following criteria: i) Discrepancy – mean percentage error between data
points and model prediction; ii) Accuracy – error between full sample species richness (purple cross) and estimated species richness from subsample;
iii) Similarity – area between subsample fit (orange) and full data fit (black); and iv) Plausibility – we require that S’(x) $0 and S"(x) #0. The best
performing models are aggregated and extrapolated to estimate species richness. Model A performs poorly as criteria ii) and iii) are not satisfied.
Model B performs well as all criteria are satisfied.
doi:10.1371/journal.pcbi.1003646.g001
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A list of 58 candidate models (Text S1) was chosen from an
online repository [54]. Many of these (e.g. logistic, logarithmic,
hyperbolic) are widely used in population ecology [11,55]. Models
were fitted by least squares regression using R version 2.14.2 [56]
with the package FME [57]. Global fitting was performed using
Price’s algorithm [58] followed by local fitting using the
Levenberg-Marquardt algorithm [59].
Study Design
We evaluated DivE and five non-parametric estimators: the
Chao1 bias-corrected estimator (Chao1bc) [36], the abundance-
based coverage estimator (ACE) [28], the Bootstrap estimator
[44], the Good-Turing estimator [45,60,61] and the widely-
used negative exponential model [11,12,36,62,63]. ACE and
Chao1 [27], have been suggested as best practice [12,14,22,29,64]
and are widely applied in microbiology and immunology
[1,30,32,34,35,37,39–43]. For ACE, ‘‘abundant’’ species were
defined as those with an observed frequency of greater than 10, as
recommended in [64].
Due to differences between estimators and between datasets, we
conducted multiple, distinct evaluations and validations. We first
evaluated, for each estimator, the relationship between estimated
diversity and sample size, using the estimates produced from a
series of successively smaller, randomly generated in silico
subsamples of observed data. For the microbial and TCR data
respectively, five and six equidistant subsample sizes were chosen
from each observed dataset. For the HTLV-1 data, subsample
sizes were chosen to be approximately equidistant; however some
were removed due to runtime constraints. See Table S1 for further
details. Second, we measured the accuracy of DivE by comparing
the estimated species richness Sˆobs at the size of the full dataset Nobs
from each subsample to the (known) species richness Sobs in the full
data. Using the same method, we compared DivE to the second
order bias-corrected Akaike Information Criterion (AICc) [65,66].
Third, the TCR data have rarefaction curves which plateau. Using
smaller subsamples of this data and making the assumption that
the species richness of the full data is equal to that of the entire
population, we were able to evaluate the accuracies of all
estimators together. Finally for 11 of the 14 HTLV-1 patients
detailed in Table S1, three samples were taken at a single time
point. For each time point, the three samples were pooled and
used as a practical test of DivE’s ability to predict species richness
in larger samples.
DivE Frequency Distribution Generation Algorithm
In addition to species richness, we wanted to estimate the
population frequency distribution. Because of the considerable
structural variation between and within immunological and
microbiological populations, we developed a general method
which does not assume the analytical form of the population
structure. This algorithm uses the DivE estimator combined with
observed abundances (Figure 2). See Text S1 for details. The
algorithm was applied to multiple random subsamples of observed
data. The estimated distributions were then compared to the full
data frequency distribution using two measurements: (i) error,
defined as the sum of discrepancies in species frequencies between
Figure 2. Outline of DivE distribution generation algorithm. A Truncated species frequency distribution with x individuals distributed among
y species. The frequency of species Si after sampling x individuals is denoted Fx(Si). B Species accumulation data generated from frequency
distribution. C An aggregate of the best performing models as returned by DivE is used to extrapolate to point (x+a, y+1), where the next species is
predicted. D Species Sy+1 is assigned a frequency of (1 - pmax)(x+a), where pmax is the maximum-likelihood proportion of individuals occupied by the y
previously observed species. The remaining pmax(x+a) individuals are distributed among species S1, …, Sy in proportion to their observed relative
frequencies at x. Steps C and D are repeated until the predicted species richness is reached. See Text S1 for further details.
doi:10.1371/journal.pcbi.1003646.g002
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estimated and observed (full) distributions, divided by the number












and (ii) percentage error between the
Gini coefficients of the estimated and observed distributions. The
Gini coefficient is an index of dispersion used widely in
epidemiology, sociology, biology, and ecology [43,67].
Results
Comparison of Estimators: Relationship between Sample
Size and Estimated Diversity
Each species richness estimator (Chao1bc [36], Bootstrap [44],
ACE [28], Good-Turing [45], the negative-exponential model
[12] and DivE) was applied to random subsamples of observed
data. We used linear regression to calculate the average
proportional increase in estimated diversity as a function of the
proportional increase in sample size. Sample size and diversity
were normalized respectively to the smallest sample and the
estimated diversity at the smallest sample. For example, a
‘‘normalized gradient’’ of 0.5 would mean that, on average, an
increase of 10% in sample size would produce a 5% increase in
estimated diversity. A value of zero would signify no bias with
sample size.
The existing estimators performed poorly when applied to the
HTLV-1 and microbial data: estimates systematically increased
with sample size. In contrast, DivE produced consistent estimates
that showed no obvious relationship with sample size (Figures 3
and 4). Across subjects and for all methods except DivE, estimates
showed significant positive normalized gradients (p,0.01 for every
estimator, n = 14; two-tailed binomial test) ranging between 0.17
and 0.52 for the HTLV-1 data and 0.3 to 0.45 for the microbial
data (Figure 4). Conversely, the normalized gradients produced by
DivE did not differ significantly from zero (p = 0.18, n = 14; two-
tailed binomial test), and were much smaller (0.0081 and 0.022 for
the HTLV-1 and microbial data respectively) (Figure 4). In any
specified population there is only one value of species richness, and
an accurate estimator will arrive at this value regardless of sample
size. An increase in estimate magnitude with sample size implies
that estimates of a population’s species richness would increase if
e.g. greater blood volumes were drawn or technique sensitivity was
improved.
The existing estimators were less biased when applied to the
TCR data, and estimates were largely consistent. Although the
normalized gradients were still significantly positive (p,0.0001 for
each estimator except DivE, n = 16), their magnitudes were
substantially lower than for the HTLV-1 and microbial data.
However, existing estimators again increased with sample size for
the effector memory (EM) CD8+ T cell population from the same
subject. These observations can be explained with reference to the
TCR rarefaction curves (Figure 3). With the exception of the
CD8+ EM dataset (for which the subsample sizes were consider-
ably smaller), each TCR rarefaction curve reached a plateau,
implying that the vast majority of observed clonotypes were
encountered early. In contrast, the CD8+ EM rarefaction curve
did not plateau, suggesting that further sampling would reveal
more CD8+ EM clonotypes. In common with the microbial and
the HTLV-1 datasets, DivE performed well for all TCR datasets,
producing consistent results from all subsample sizes. To make sure
that the smallest subsamples did not disproportionately contribute
to the observed gradients, we repeated the above analysis using only
estimates from the largest three subsamples in each patient dataset,
which showed almost identical results (Figure S1).
Comparison of DivE and Second Order Bias-Corrected
Akaike Information Criterion (AICc)
The best-performing models were largely consistent within
patients and between subsamples for the microbial and TCR
data, although less so for the HTLV-1 data. Ideally, model
selection would be consistent across all subsamples. Deviation
from this will result in a discrepancy between Sobs and Sˆobs. This
discrepancy is quantified in Figure 3 (middle column) and in Table
S2. To ensure the four criteria provide a useful metric of model
performance, we compared DivE to the second order bias-
corrected Akaike Information Criterion(AICc) [65,66]. DivE’s
mean errors (between the species richness of the full data Sobs and
Sˆobs) were 3.3%, 1.0%, and 4.0% for the HTLV-1, TCR and
microbial data respectively. These were lower than the corre-
sponding errors of 6.7%, 1.1%, and 7.5%, produced when models
were scored by the AICc. This effect was more marked when we
considered estimates from small subsamples, defined as those
comprising at most 50% of the observed data (Table S2).
However, the differences between errors were smaller for the
TCR data, perhaps also due to the saturating rarefaction curves in
these samples.
Comparison of Estimators: Accuracy of Diversity Estimate
When rarefaction curves reach a plateau, we can assume that
the value of the plateau is approximately equal to the species
richness of the entire population, which the existing estimators aim
to estimate. Thus it is appropriate to evaluate DivE and the existing
estimators together using TCR rarefaction curves which plateau.
We took random subsamples of 0.5%, 1%, 2%, 5%, and 10% of
the total CD4+ and CD8+ cells for subjects C and E. We then
applied each estimator to each subsample and measured its error
( = |Sobs - Sˆobs| /Sobs) (Table 1, Figure S2). DivE’s median error
was 6.7%, substantially lower than respective median errors of
43.8%, 42.8%, 65.3%, 61.7%, and 50.7% for the Chao1bc,
ACE, Bootstrap, Good-Turing and negative exponential estima-
tors (p,0.0005 for each estimator comparison with DivE, n = 20;
two-tailed binomial test)
As neither the HTLV-1 nor the microbial data exhibit
rarefaction curves that plateau, we cannot apply the same analysis
to these datasets. Instead we took advantage of the fact that, for 11
of the 14 HTLV-1 subjects, the data comprised three time
points,with three samples drawn at each time point in immediate
succession from the subject. For a given subject and a single time
point, the three samples were combined in silico to produce a single
pooled sample. We compared the observed species richness of the
pooled sample to each estimator’s estimates from a subsample
(Figure 5, Figure S3). The total blood diversity must be at least as
great as that observed by pooling the samples. However, all
existing estimators estimate the total diversity to be less than that
observed. Based on a single subsample, the Chao1bc, ACE,
Bootstrap, Good-Turing and negative exponential estimators
respectively estimate medians of 27.0%, 12.7%, 71.1%, 65.5%,
and 47.6% fewer clones than observed in the pooled samples
(n = 11). Since the pooled samples do not saturate, and since
the blood contains approximately 105 times more infected cells
than the pooled sample, the diversity observed in the pooled
sample is likely to be a small fraction of the total diversity. Since
the existing estimators produce estimates lower than the
pooled sample diversity, let alone total blood diversity, this
represents a considerable error. We used DivE to produce two
estimates: the pooled sample diversity and blood diversity. From
the subsamples DivE estimated a median of 2.66103 clones in the
pooled samples, a median error of 2.5% (n = 11) (Figure 5, Figure
S3). Additionally, DivE estimated 2.86104 clones in the blood,
Quantifying HTLV-1 Clonality and TCR Diversity
PLOS Computational Biology | www.ploscompbiol.org 5 June 2014 | Volume 10 | Issue 6 | e1003646
Figure 3. Comparison of species richness estimators. A–D The Chao1bc (blue), ACE (grey), Bootstrap (green), Good-Turing (black), and
negative-exponential estimators (orange) are applied to in silico random subsamples of observed data. Examples for HTLV-1, microbial, and TCR data
are shown. Estimates systematically increase with sample size in datasets where rarefaction curves do not plateau (e.g. in I, J, K). Where rarefaction
curves do plateau (e.g. in L), estimates are consistent. E–H DivE (red) is applied to same subsamples as the other estimators. Performance of DivE was
evaluated by comparing the error of estimates (Sˆobs), to the (known) number of species Sobs in the full observed data (purple line), i.e. error = |Sobs -
Sˆobs| /Sobs. In all datasets, DivE accurately estimates the species richness of the full observed data from subsamples of that data. I–L Corresponding
HTLV-1, microbial and TCR rarefaction curves: arrows denote the size of the subsample to which each estimator was applied.
doi:10.1371/journal.pcbi.1003646.g003
Quantifying HTLV-1 Clonality and TCR Diversity
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approximately one log higher than the observed pooled sample
diversity. Whilst we cannot determine whether or not this is
accurate it is at least plausible, considering that it is not less than
the diversity of the pooled sample, that the sampling fraction is
very small, and that the rarefaction curve has not reached a
plateau.
Figure 4. Comparison of estimators: Effect of sample size on estimated diversity. Normalized gradients measuring proportional increase in
estimated diversity against proportional increase in sample size. Normalized gradients (shown for each estimator and each patient data set in Table
S1) were calculated by linear regression. For the HTLV-1 and microbial data, all estimators except DivE show large normalized gradients that are
significantly positive. The TCR normalized gradients, though significantly positive, are small and do not show a substantial bias with sample size.
*, **, and *** signify p,0.01, p,0.001, and p,0.0001 respectively; two-tailed binomial test (n = 14, 16, 20 for the HTLV-1, TCR and microbial data
respectively).
doi:10.1371/journal.pcbi.1003646.g004
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Estimate Error as a Function of Data Curvature
Next we sought to identify conditions under which DivE would
be prone to error and should not be applied. When the observed
rarefaction curve is linear, the data imply a constant rate of species
accumulation, and so provide little information on how quickly
the rate of species accumulation will decrease. This is usually
indicative of severe under-sampling. We predicted that DivE will
fail to give accurate estimates given such a near linear rarefaction
curve. We tested this prediction by calculating the error in the
DivE estimates as a function of rarefaction data curvature.
The curvature Cp was quantified by the area between the
observed rarefaction curve and a linear rarefaction curve, as a
fraction of the maximum possible area, which occurs when
the rarefaction curve saturates immediately. Cp can take values
between 0 and 1, where 1 reflects perfect saturation and 0 reflects
a constant rate of species accumulation (Figure S4). We took
additional samples of 0.1% of the total CD4+ and CD8+ cells for
subjects C and E to obtain lower curvature values.
As expected, at very low curvatures (0.016#Cp#0.101), DivE
was prone to overestimation and performed poorly (Figure 6), with
median error 0.23. However, for under-sampled populations of
intermediate curvature (0.11#Cp#0.62) DivE improved markedly
(median error = 0.06), and typically outperformed the other
estimators (Figure 6, Table S3). Finally, all estimators perform well
when the curvature is high and most of the diversity has been
observed (Figure 3D, 3H and 3L).
We next tested DivE using the Prochlorococcus data [52], with
multiple subsamples of increasing curvature (as for the TCR data).
At low curvatures DivE again performed poorly, but it became
more accurate as the curvature increased. For under-sampled
populations of intermediate curvature, DivE again outperformed
the other estimators, although the differences between the
estimator errors were not as dramatic as with the TCR data
(Figure S5).
Very low curvatures suggest severe under-sampling and
researchers should exercise caution with such data. It is unlikely
that any species richness estimator will be accurate or informative
in such cases.
Example Application: Estimated Number of HTLV-1
Infected Cell Clones
In both HTLV-1 infection and infection with the related bovine
leukaemia virus (BLV), accurate determination of the number of
infected cell clones in the host is critical to understanding retroviral
dynamics and pathogenesis [68-71]. Here we make two different
estimates of the number of HTLV-1 infected cell clones: (i) in the
circulation; and, (ii) in the whole body. See Text S1 for details of
HTLV-1 population size estimation.
The mean estimated number of clones in the circulation in a
single host was 2.96104. It is unknown whether the population
structure of HTLV-1 clones in the blood reflects that in solid
lymphoid tissue and the spleen. If we assume that these two
populations have similar structures, and thus that it is justified to
extrapolate to the whole body, we obtain an average of 6.26104
clones, i.e. approximately only twice as many clones, although
there are .300 times as many infected cells in the body as
the blood. These new estimates in the blood and body are
approximately 1 and 1.3 logs higher respectively than those
calculated using ACE and Chao1bc (p,0.0001, two-tailed paired
Mann-Whitney U-test), and .2 logs higher than previously
published estimates (Figure S6) [35,43,69,72].
DivE Uncertainty
Because of its heuristic nature, DivE lacks formal statistical
confidence intervals. Uncertainty in the estimates produced by
DivE has two sources: parameter values in each respective model
(within-model variation), and the choice of model (between-model
variation). Using standard errors of parameter estimates to
calculate confidence intervals ignores uncertainty from model
selection. Information theoretic approaches that take account of
model selection uncertainty have become increasingly common in
ecology [73,74] and elsewhere. There are broadly two approaches:
i) computing AIC weights, and ii) repeated resampling and model
ranking to determine bootstrap model selection probabilities [66].
However, neither approach is appropriate in our case. We do not
rank models using AIC since this produces less accurate estimates
Table 1. Comparison of estimator performance for TCR data.







*Median absolute percentage error between Sobs and Sˆobs.
{p-value of the significance of the differences between the errors of each
estimator and DivE (n = 24; two-tailed binomial test).
doi:10.1371/journal.pcbi.1003646.t001
Figure 5. Existing estimators underestimate diversity in HTLV-
1 infection. For HTLV-1 Patient D, three samples are pooled.
Rarefaction curves from the pooled sample (black circles) and a
subsample (red circles) are shown. Chao1bc, ACE, Bootstrap, Good-
Turing and negative exponential estimates (blue, grey, green, black, and
orange lines respectively) from the subsample, and DivE estimates (red
cross) from the same subsample are plotted. Existing estimators
produce a single estimate of diversity, and so their estimates are shown
as lines. The diversity in the blood must be at least as great as that
observed by pooling the samples. All existing estimators estimate the
total diversity to be less than that observed. Given that the observed
diversity is likely to be a small fraction of the total diversity this
represents a considerable error. We used DivE to produce two
estimates: the diversity in the pooled sample (i.e. in 15000 cells, red
cross) and the total diversity of the blood. DivE accurately estimates the
pooled sample species richness from the subsample, but also predicts
higher values of species richness in the blood, consistent with the
unseen clones implied by the pooled rarefaction curve. See Figure S3
for further examples.
doi:10.1371/journal.pcbi.1003646.g005
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than DivE (Table S2), and so we cannot use AIC weights to derive
confidence intervals. Further, since there is a systematic bias
towards lower species richness in bootstrap samples (Figure S7), a
similar bias may be introduced in the estimation of bootstrap
model selection probabilities, leading in turn to a bias in species
richness estimation. Systematic underestimation in bootstrap
samples is particular to species richness estimation: this does not
highlight a general problem with resampling to quantify model
selection uncertainty. As a pragmatic indicator of estimate
variability, we use the range of estimates produced by the five
best-performing models; the geometric mean of these five models
is taken as the point estimate (Table S4).
Distribution Generation Algorithm
The distribution generation algorithm was reasonably accurate
for the HTLV-1 data, and considerably more accurate for the
TCR and microbial data. The mean error between the estimated
and true distributions was 32.1%, 2.9%, and 4.9% for the HTLV-
1, TCR and microbial data respectively. The mean error between
the estimated and true Gini coefficients was 7.5%, 0.9%, and 2.2%
for the HTLV-1, TCR and microbial data respectively (Table 2).
For the HTLV-1 data, the algorithm underestimated the
abundance of the largest clones, but we did not observe this effect
in the TCR and microbial data (Figure 7).
Discussion
We wished to estimate species richness in three microbiological
and immunological datasets. Initially we used estimators that
are reported to perform well in ecology [12,34,36,60,61,75]. In
the datasets with rarefaction curves that did not plateau,
these estimators were biased by sample size. For datasets with
rarefaction curves that did plateau, estimates were consistent,
but in such cases estimators contribute little information because
approximate species richness is already known. Comparable
results have been reported elsewhere [12,16,62]. By combining
data from multiple independent HTLV-1 samples, we showed that
these estimators substantially underestimated species richness.
We then developed a new approach, DivE, to estimate species
richness and frequency distribution. In our first validation, DivE
consistently and accurately estimated the diversity of the observed
data from incomplete subsamples of that data. We subsequently
determined conditions where DivE would fail and should not be
applied. When the rarefaction curvature was low and the data
implied a near-constant species-accumulation rate, DivE was
prone to overestimation. However, in under-sampled populations
of intermediate curvature, DivE substantially improved. The DivE
distribution generation algorithm performed with reasonable
accuracy (Table 2, Figure 7).
Figure 6. Test of species richness estimators at different values of curvature parameter (Cp) using TCR data. The curvature parameter
Cp is plotted against the relative error (|Sobs - Sˆobs| /Sobs) of each estimator. Four patient data sets are shown: A total CD4
+ from patient C; B total CD4+
from patient E; C total CD8+ from patient C; D total CD8+ from patient E. Each point represents an estimate from a subsample of data. Note the plots
have different y-axis scales and the y-axes in C and D are segmented. Broadly, the accuracy of all estimators improves as Cp increases, and this
increase is more pronounced for DivE. From Cp.0.1, DivE generally outperforms the existing estimators, but is prone to error at very low values of Cp.,
when the rarefaction curve implies a near-constant rate of species accumulation.
doi:10.1371/journal.pcbi.1003646.g006
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We argue that biologically meaningful and useful estimators
should be able to estimate species richness in a specified
population. This is not the case with the existing estimators
we tested. In contrast, DivE can estimate diversity in any given
population size. However, population size estimation can be
nontrivial [76–78]. In spatially homogeneous populations with
equiprobable detection of individuals, estimating population size
through scaling by area or volume is justifiable e.g. scaling from
cells in 50 ml of blood to cells in the total blood volume. When
population size estimates are unavailable, it is still usually possible
to provide meaningful diversity estimates, e.g. the number of
microbes per gram of faeces. DivE may also be useful in deciding
the depth of sampling required for an adequate census. Deeper
sampling may require more DNA sequencing or a larger tissue
sample from a patient, and so minimizing sampling depth has
financial and ethical benefits. This is not possible with the other
estimators we tested.
The HTLV-1 data consisted of absolute species counts, and so
we could estimate HTLV-1 diversity. Microbial and TCR datasets
were used only for validation as these data consisted of sequence
reads and not absolute counts. To the extent that read abundances
differ from absolute counts, such data cannot be used to estimate
species richness with any abundance-based estimator (e.g. DivE,
Chao1bc, and ACE). Over-amplification by PCR may generate a
saturating rarefaction curve that is not due to sampling depth,
falsely implying that the majority of species have been observed.
This can be seen in our TCR data: plateaus were far lower than
previously reported diversity estimates [50,79]. However, absolute
counts can often be obtained (e.g. by spiking a sample with a
known quantity of identifiable individuals or by barcoding to
identify PCR duplicates).
It is unlikely that sequencing error influenced our HTLV-1
diversity estimates, because sequencing error cannot systematically
alter proviral integration site mapping. However, species richness
estimates from TCR or microbial data are likely to be susceptible
to sequencing error. Sequencing error can falsely increase
diversity, and this will influence species richness estimates using
any estimator; researchers must therefore exercise caution when
analysing such data; ideally by preprocessing the data to remove
error prior to further analysis. Caution must also be exercised
when assuming that the spatial distribution of individuals is
uniform. We believe that these assumptions are reasonable for the
blood, but skin tissue for example may be more clustered.
DivE is conceptually simple but can be computationally
intensive to implement. When applying DivE to a new type of
data it is necessary to ascertain which models perform best. This
requires that many models be fitted to multiple subsamples. If, for
a particular data type, a given set of models performs consistently
well, application becomes much quicker because only these models
need to be fitted, and it is no longer necessary to fit all models to all
subsamples. In our analysis we found that five models performed
consistently well, and so we have used the aggregate of the
five best-performing models in our estimates. Since the optimal
number of models may differ between datasets, we advocate
careful analysis of model scores to decide how many models should
be aggregated. The DivE estimator has been provided as an R
package, available at http://cran.r-project.org/web/packages/
DivE/index.html.
In summary, we have developed and validated a new approach
to estimate species richness and distribution that significantly
outperformed existing estimators of biodiversity in the datasets we
examined.
Figure 7. Validation of DivE distribution generation algorithm. The DivE distribution generation algorithm (Figure 2) was applied to random
samples (red dashed) of observed data (black solid). Accuracy was evaluated by comparing the estimated distribution (orange dashed) to the true
distribution of the full observed data (black). Examples for HTLV-1 A, TCR B and microbial datasets C are shown.
doi:10.1371/journal.pcbi.1003646.g007
Table 2. Performance of DivE frequency distribution
generation algorithm.




*Mean error across all subjects and all small subsamples, for each data source.
Small subsamples were defined as those #50% of the size of the observed
each patient data set. Error defined as the sum of absolute discrepancies between
true and estimated frequency distributions, divided by area under true
distribution.
{Mean percentage error across all subjects and all small subsamples in the Gini
coefficients of the true and estimated distributions.
doi:10.1371/journal.pcbi.1003646.t002
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Supporting Information
Figure S1 Estimator bias with sample size not due to
subsamples. As for Figure 4, except that normalized gradients
calculated using only largest three subsamples. For the HTLV-1
and microbial data, all estimators except DivE again show large
normalized gradients that are significantly positive. The TCR
normalized gradients, show no bias with sample size. *, **, and
*** signify p,0.05, p,0.01, and p,0.001 respectively; two-tailed
binomial test (n = 14, 16, 20 for the HTLV-1, TCR and microbial
data respectively).
(TIF)
Figure S2 Comparison of estimators: Accuracy of
diversity estimates using TCR data. Random subsamples
of 0.5%, 1%, 2%, 5%, and 10% of the total CD4+ and CD8+ cells
for subjects C and E were taken, and each estimator was applied to
each subsample. These populations have rarefaction curves that
plateau, so making the assumption that the value of the plateau Sobs
is the diversity of the whole population, the distribution of errors
for each estimator ( = |Sobs - Sˆobs| /Sobs) is shown.
(TIF)
Figure S3 Existing estimators underestimate diversity
in HTLV-1 infection. As for Figure 5. For each patient, three
independent samples are pooled. Rarefaction curves from the
pooled sample (black circles) and a subsample (red circles) are
shown. Chao1bc, ACE, Bootstrap, Good-Turing and negative
exponential estimates (blue, grey, green, black, and orange lines
respectively) from the subsample, and DivE estimates (red cross)
from the same subsample are plotted. All estimators except DivE
typically estimate fewer clones than observed in pooled sample. In
contrast, DivE accurately estimates the pooled sample species
richness from the subsample.
(TIF)
Figure S4 Rarefaction curvature parameter Cp. Rarefac-
tion curves (dashed) and lines of constant rate of species-accumulation
and perfect saturation (solid) are shown. Areas between the line of
constant rate of species-accumulation and the rarefaction curve (A),
and between the rarefaction curve and the line of perfect saturation
(B) are indicated. Note Cp = 0 when the rarefaction curve is linear.
(TIF)
Figure S5 Performance of species richness estimators
in metagenomic data. The curvature parameter Cp is plotted
against the relative error (|Sobs - Sˆobs| /Sobs) of each estimator. Each
point represents an estimate from a sample from the Prochlorococcus
data. As with the TCR data, DivE typically outperforms the other
estimators from Cp<0.1 onwards. As predicted, DivE is prone to error
at lower values of Cp, but becomes more accurate as Cp increases.
(TIF)
Figure S6 Diversity estimates in HTLV-1 infection by
estimator. Each estimator was applied to 105 patient datasets,
from 14 different HTLV-1+ subjects. All subjects either had
HTLV-1-associated myelopathy/tropical spastic paraparesis or
were asymptomatic.
(TIF)
Figure S7 Rarefaction plots from bootstrap samples of
HTLV-1, TCR, and microbial data. Rarefaction plots from
100 bootstrap samples (grey) for each of A HTLV-1, B TCR, and
C microbial data. The species richness of the bootstrap samples is
at most the species richness of the original data (black), and is
substantially less in the majority of cases, although this effect is less
noticeable with the TCR data.
(TIF)
Table S1 Subsamples used in analysis of relationship
between sample size and estimated diversity, and in
comparison of DivE with AICc. 1 Where there were multiple
samples at multiple time points in a given HTLV-1-infected
subject, a single sample at a single time point was chosen at
random.
(PDF)
Table S2 Comparison of estimates produced by DivE
and by weighted, second order Akaike’s Information
Criterion (AICc). 1 Average percentage error between Sobs and
Sˆobs for small subsamples for each data source. Small subsamples
were defined as those #50% of the size of each patient data set. 2
Large subsamples defined as those .50% of the size of each
patient data set. 3 Average percentage error between Sobs and Sˆobs
across all patient datasets and subsamples for each data source
error.
(PDF)
Table S3 Estimator error variation with curvature in
TCR data. * Median absolute percentage error between Sobs and
Sˆobs. { Low curvatures Cp in range 0.016#Cp#0.101, interme-
diate curvatures in range 0.11#Cp#0.62. { p-value of the
significance of the differences between the errors of DivE and
each other estimator, for each curvature range.
(PDF)
Table S4 DivE species richness estimates for HTLV-1
data.
(PDF)
Text S1 Additional supporting information.
(PDF)
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